Sean MacDonald's most recent trade in Edesa Biotech Inc was a trade of 20,001 Common Shares done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edesa Biotech Inc | Sean MacDonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 20,001 | 22,054 (0%) | 0% | 0 | Common Shares | |
| Edesa Biotech Inc | Sean MacDonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2023 | 20,000 | 20,000 | - | - | Share Option (right to buy) | |
| Edesa Biotech Inc | Sean MacDonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| Edesa Biotech Inc | Sean MacDonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Edesa Biotech Inc | Sean MacDonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2020 | 20,000 | 20,000 | - | - | Stock option (right to buy) |